Induction of Pancreatic Islet Cell Tumors in Rats by Repeated Intravenous Administration of 4-Hydroxyaminoquinoline 1-Oxide

Toxicologic Pathology - United States
doi 10.1080/019262301316905273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Mutagenic Activity of 4-Nitroquinoline 1-Oxide and 4-Hydroxyaminoquinoline 1-Oxide on Bacteria

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1965English

Investigation About Preoperative Diagnostic Imagings of Pancreatic Islet Cell Tumors

The journal of the Japanese Practical Surgeon Society
1992English

Induction of Insulin and Islet Amyloid Polypeptide Production in Pancreatic Islet Glucagonoma Cells by Insulin Promoter Factor 1.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Immunohistochemistry of Pancreatic Islet Cell Tumors in the Ferret (Mustela Putorius Furo)

Veterinary Pathology
Veterinary
1997English

Transplantation of Islet Cell Tumors Induced by Streptozotocin.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1980English

Pharmacological Induction of Pancreatic Islet Cell Transdifferentiation: Relevance to Type I Diabetes

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2014English

Disruption of Spindle Checkpoint Function Ahead of Facilitation of Cell Proliferation by Repeated Administration of Hepatocarcinogens in Rats

Journal of Toxicological Sciences
MedicineToxicology
2015English

ISL-1 Promotes Pancreatic Islet Cell Proliferation by Forming an ISL-1/Set7/9/PDX-1 Complex

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2015English

Effects of Intravenous Administration of Pentoxifylline in Pancreatic Ischaemia–reperfusion Injury

HPB
HepatologyGastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy